Trial Profile
An Open Label, Single Dose Study to Characterize the Pharmacokinetics and Pharmacodynamics of Prasugrel in Healthy Male Adult Subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary)
- Indications Acute coronary syndromes; Sickle cell anaemia; Stroke
- Focus Pharmacokinetics
- 21 Mar 2014 New trial record